Visicol maker calls kidney failure reports misleading
Salix Pharmaceuticals is calling a recent report linking its bowel prep drug to kidney failure misleading. Consumer advocacy group Public Citizen had cited a study in the Journal of the American Society of Nephrology calling bowel-cleansing products containing sodium phosphate an ?underrecognized? cause of chronic kidney failure.
Visicol maker calls kidney failure reports misleading
Salix Pharmaceuticals is calling a recent report linking its bowel prep drug to kidney failure misleading. Consumer advocacy group Public Citizen had cited a study in the Journal of the American Society of Nephrology calling bowel-cleansing products containing sodium phosphate an “underrecognized” cause of chronic kidney failure. Salix’s executive director of medical affairs said the report did not clarify that of the 21 cases of kidney failure, only one could be attributed to Visicol, while the other 20 were caused by Fleet Phospho-Soda. He also stated that the one affected Visicol patient was at increased risk because he had underlying renal dysfunction, was taking an ACE inhibitor, and was not properly hydrated.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
